Select your language/region

Resources

These publications may include information from one or more organism/antimicrobial combinations that are research use only and not for use in diagnostic procedures. Certain uses of devices included in these publications may not have been IVD-approved or cleared by regulatory bodies.

Type Title Download
Poster The LIFETIMES Study – Interim Results from a Health and Economic Evaluation of a Rapid Phenotypic AST System, ASM Microbe 2024.
Poster Rapid AST expedites antimicrobial therapy optimisation in BSI patients – clinical cases from the LIFETIMES HEOR study, ESCMID Global 2024.
White Paper The Health and Economic Impact of Rapid AST in the Management of Bloodstream Infections
Brochure ASTar - Designed to save lifetimes (US version)
Poster A new assay for rapid antimicrobial susceptibility testing of bloodstream infection-causing gram-negative bacteria, ASM 2023.
Poster Performance Evaluation for Piperacillin/Tazobactam in ESBL-Producing E. coli Strains (OXA-1 and TEM-1) in an Automated Rapid AST System Using the New FDA Breakpoints, ASM 2023.
Poster Fully Automated Phenotypic Resistance Reporting in 3 Hours, Directly from a Positive Blood Culture, ECCMID 2021.
Poster Accurate inoculum preparation for AST from various samples, ASM 2019.
Poster Rapid phenotypic AST direct from different clinical specimens as well as isolates on the same automated system, ECCMID 2019.
Poster Automated inoculum preparation for AST from crude samples, ECCMID 2019.
Poster Antimicrobial Susceptibility Test System Delivering Phenotypic MICs in Hours from Positive Blood Cultures for Fastidious- and Non-Fastidious Pathogens, ASM 2018.
Poster Opportunity for very rapid phenotypic susceptibility testing of clinical specimens using the novel ASTar platform, ASM 2018.
Poster MALDI-TOF MS Identification and Phenotypic AST Delivering True MICs in Hours, Directly from Clinical Positive Blood Cultures, ASM 2018.
Poster Mass spectrometry pathogen identification and phenotypic antimicrobial susceptibility testing delivering MICs in hours, directly from clinical positive blood cultures, ECCMID 2018.
White Paper The Importance of Controlled Inoculum
Poster Performance of a rapid phenotypic AST System for susceptibility testing of Gram-negative bacteraemia directly from positive blood culture bottles, ECCMID 2022.
Poster Using wasted time: How a portable culture device can reduce the impact of transportation times in antimicrobial susceptibility testing, ECCMID 2022.
Poster Rapid phenotypic AST System performance for Gram-negative bacteraemia susceptibility testing directly from positive blood culture bottles, ASM 2022.
Poster Using wasted time: How a portable culture device can reduce the impact of transportation times in antimicrobial susceptibility testing, ASM 2022.

Presentations & webinars

UPCOMING WEBINAR
Clinical Evaluation of an FDA-Cleared High-Throughput Rapid Antibiotic Susceptibility Testing System

Date: Wednesday, September 18, 2024

Time: 10 AM PT, 1 PM ET (7 PM CET)

Speakers:

Elizabeth Garrett, PhD, D(ABMM)
Associate Director of Microbiology, Penn State Hershey Medical Center

Rebecca Yee, PhD, D(ABMM), M(ASCP)
Chief of Microbiology, Assistant Professor of Pathology, George Washington University

Register here

Clinical Impact of rapid antimicrobial susceptibility testing on positive blood cultures from 200 patients with bacteremia: A prospective trial
Pr. Alexia Verroken, MD, PD

Clinical Microbiology laboratory-Cliniques universitaires Saint-Luc-Brussels-Belgium

View presentation

Recorded presentation from a workshop held at the AMCLI Congress, March 2024

LIFETIMES – Risultati preliminari di uno studio multcentrico di Health Economics (English subtitles)
Prof. Maurizio Sanguinetti

Universitá Cattolica del Sacro Cuore, Rome, Italy.

View presentation

Disclaimer

Publications and posters on this page may include performance information for device which is not US-FDA cleared or CE-IVD marked. See Instruction for Use for performance and limitations specific for each device and region.